Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialRavi A. Madan, James L. Gulley, Kwong Y. Tsang et al.|The Lancet Oncology|2012Cited by 327
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancerJames L. Gulley, Jeffrey Schlom, Philip M. Arlen et al.|Cancer Immunology Immunotherapy|2009Cited by 298
Increased Frequency of Venous Thromboembolism with the Combination of Docetaxel and Thalidomide in Patients with Metastatic Androgen‐Independent Prostate CancerMcDonald K. Horne, William L. Dahut, Howard L. Parnes et al.|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2003Cited by 40